CD70 antibody based drugs: two different mechanisms of action for the treatment of multiple cancer types

被引：0

作者：

Terrett, Jonathan A. ^{[1
]}

Pan, Chin ^{[1
]}

Gangwar, Sanjeev ^{[1
]}

Lu, Lisheng ^{[1
]}

Chen, Liang ^{[1
]}

Rao, Chetana ^{[1
]}

Huber, Mary ^{[1
]}

Sattari, Peter ^{[1
]}

Do, Mary ^{[1
]}

Dai, Rory ^{[1
]}

Chong, Colin ^{[1
]}

Soderberg, Carol ^{[1
]}

Li, Hao ^{[1
]}

Sufi, Bilal ^{[1
]}

Boyd, Sharon ^{[1
]}

Huang, Haichun ^{[1
]}

Zhang, Jun ^{[1
]}

Meaddough, Erika ^{[1
]}

Guerlavais, Vincent ^{[1
]}

Horgan, Killian ^{[1
]}

Sharkov, Nick ^{[1
]}

Cardarelli, Pina ^{[1
]}

King, David ^{[1
]}

Yao, Dapeng ^{[1
]}

Pogue, Sarah ^{[1
]}

机构：

[1] Medarex Inc, Milpitas, CA USA

来源：

CANCER RESEARCH | 2006年 / 66卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1995

引用

页数：2

共 50 条

[41] A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies [J].

Deckert, Jutta ;

Park, Peter U. ;

Chicklas, Sharon ;

Yi, Yong ;

Li, Min ;

Lai, Katharine C. ;

Mayo, Michele F. ;

Carrigan, Christina N. ;

Erickson, Hans K. ;

Pinkas, Jan ;

Lutz, Robert J. ;

Chittenden, Thomas ;

Lambert, John M. .

BLOOD, 2013, 122 (20) :3500-3510

[42] Two Cd-MOFs with different types of channels based on phenylimidazole dicarboxylic acids: Synthesis, crystal structure and solid fluorescence properties [J].

Jiang, Yuxuan ;

Dong, Jianping ;

Sun, Fugang ;

Li, Ruixue ;

Wu, Huilu .

JOURNAL OF MOLECULAR STRUCTURE, 2022, 1250

[43] Use of biologic therapies with different mechanisms of action (MOA) in the first-line (1L) treatment of Crohn's Disease (CD) in the US [J].

Huang, Z. ;

Ba, Y. ;

Kamble, P. ;

Wang, S. .

JOURNAL OF CROHNS & COLITIS, 2021, 15 :S084-S084

[44] Use of Biologic Therapies With Different Mechanisms of Action (MOA) in the First-line (1L) Treatment of Crohn's Disease (CD) in the US [J].

Huang, Zhongwen ;

Ba, Yi ;

Kamble, Pravin ;

Wang, Song .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 :S433-S433

[45] Evaluation of deep learning based dose prediction in head and neck cancer patients using two different types of input contours [J].

Saito, Masahide ;

Kadoya, Noriyuki ;

Kimura, Yuto ;

Nemoto, Hikaru ;

Tozuka, Ryota ;

Jingu, Keiichi ;

Onishi, Hiroshi .

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2024, 25 (12)

[46] Gene expression profiling (GEP) after short term in-vivo treatment identifies potential mechanisms of action of current drugs used to treat multiple myeloma. [J].

Shaughnessy, J ;

Zhan, FH ;

Kordsmeier, B ;

Randolph, C ;

McCastlain, K ;

Barlogie, B .

BLOOD, 2002, 100 (11) :208A-208A

[47] Case report: Different mechanisms of drug resistance in a synchronous multiple primary lung cancer patient after EGFR-TKI treatment [J].

Xie, Shaonan ;

Liu, Qingyi .

FRONTIERS IN ONCOLOGY, 2022, 12

[48] Comparisson of molecular mechanisms altered by treatment with different drugs (Doxorubicin, Melphalan, Bortezomib, Aplidin and Arsenic Trioxide) in multiple myeloma patients using oligonucleotide microarrays. [J].

Maiso, P ;

Gutierrez, NC ;

Lopez-Perez, R ;

Mateo, G ;

Isidro, IM ;

Ferminan, E ;

Carvajal-Vergara, X ;

Montero, JC ;

Hernandez, JM ;

Pandiella, A ;

Miguel, JFS .

BLOOD, 2004, 104 (11) :674A-675A

[49] Crystal plasticity-based forming limit analysis for two types of 5052 aluminum alloy sheets with different heat treatment conditions [J].

Sato, Sho ;

Tsukamoto, Maya ;

Maeda, Yasuhiro ;

Maeda, Yasushi ;

Hama, Takayuki .

MATERIAL FORMING, ESAFORM 2024, 2024, 41 :1009-1016

[50] Assessment of the activity of an oral contraceptive on the levels of oxidative stress and changes in oxidative stress after co-treatment with two different types of physiological modulators with antioxidant action [J].

Finco, Annarosa ;

Belcaro, Gianni ;

Cesarone, Maria Rosaria .

CONTRACEPTION, 2011, 84 (04) :418-422

← 1 2 3 4 5 →